prof. Isabel Leroux-Roels

Journal Article
A1
open access

Immune responses in healthy adults elicited by a bivalent norovirus vaccine candidate composed of GI.4 and GII.4 VLPs without adjuvant

Gwenn Waerlop (UGent) , Yorick Janssens (UGent) , Bart Jacobs (UGent) , Franziska Jarczowski, André Diessner, Geert Leroux-Roels (UGent) , Victor Klimyuk, Isabel Leroux-Roels (UGent) and Frank Thieme

(2023) FRONTIERS IN IMMUNOLOGY. 14.

Add to list

Journal Article
A1
open access

Safety and immunogenicity of a respiratory syncytial virus prefusion F (RSVPreF3) candidate vaccine in older adults : phase 1/2 randomized clinical trial

Isabel Leroux-Roels (UGent) , Matthew G Davis, Katie Steenackers, Brandon Essink, Corinne Vandermeulen, Charles Fogarty, Charles P Andrews, Edward Kerwin, Marie Pierre David, Laurence Fissette, et al.

(2023) JOURNAL OF INFECTIOUS DISEASES.

Add to list

Journal Article
A1
open access

Human immunity and susceptibility to influenza A(H3) viruses of avian, equine, and swine origin

Elien Vandoorn (UGent) , Wojciech Stadejek (UGent) , Isabel Leroux-Roels (UGent) , Geert Leroux-Roels (UGent) , Anna Parys (UGent) and Kristien Van Reeth (UGent)

(2023) EMERGING INFECTIOUS DISEASES. 29(1). p.98-109

Add to list

Journal Article
A1
open access

Respiratory syncytial virus prefusion F protein vaccine in older adults

Alberto Papi, Michael G. Ison, Joanne M. Langley, Dong-Gun Lee, Isabel Leroux-Roels (UGent) , Federico Martinon-Torres, Tino F. Schwarz, Richard N. van Zyl-Smit, Laura Campora, Nancy Dezutter, et al.

(2023) NEW ENGLAND JOURNAL OF MEDICINE. 388(7). p.595-608

Add to list

Journal Article
A1
open access

Double-blind, placebo-controlled, dose-escalating study evaluating the safety and immunogenicity of an epitope-specific chemically defined nanoparticle RSV vaccine

Isabel Leroux-Roels (UGent) , Jacques Bruhwyler, Lilli Stergiou, Mark Sumeray, Jasper Joye (UGent) , Cathy Maes, Paul-Henri Lambert and Geert Leroux-Roels (UGent)

(2023) VACCINES. 11(2).

Add to list

Journal Article
A1
open access

Practice testing of generic quality indicators for responsible antibiotic use in nine hospitals in the Dutch–Belgian border area

A.A. Monnier, Valentino D'Onofrio (UGent) , I. Willemsen, M.F.Q. Kluytmans-van den Bergh, J.A.J.W. Kluytmans, A. Schuermans, Isabel Leroux-Roels (UGent) and I.C. Gyssens

(2022) JOURNAL OF HOSPITAL INFECTION. 129. p.153-161

Add to list

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2) : results of a randomised, double-blind, placebo-controlled, phase 3 trial

Karin Hardt, An Vandebosch, Jerald Sadoff, Mathieu Le Gars, Carla Truyers, David Lowson, Ilse Van Dromme, Johan Vingerhoets, Tobias Kamphuis, Gert Scheper, et al.

(2022) LANCET INFECTIOUS DISEASES. 22(12). p.1703-1715

Add to list

Journal Article
A1
open access

A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccine

Isabel Leroux-Roels (UGent) , Cathy Maes, Jasper Joye (UGent) , Bart Jacobs (UGent) , Franziska Jarczowski, André Diessner, Yorick Janssens (UGent) , Gwenn Waerlop (UGent) , Kirsi Tamminen, Suvi Heinimäki, et al.

(2022) FRONTIERS IN IMMUNOLOGY. 13.

Add to list

Journal Article
A1
open access

The role of cell-mediated immunity against influenza and its implications for vaccine evaluation

Yorick Janssens (UGent) , Jasper Joye (UGent) , Gwenn Waerlop (UGent) , Frédéric Clement (UGent) , Geert Leroux-Roels (UGent) and Isabel Leroux-Roels (UGent)

(2022) FRONTIERS IN IMMUNOLOGY. 13.

Add to list

Journal Article
A1
open access

Randomized, double-blind, reference-controlled, phase 2a study evaluating the immunogenicity and safety of OVX836, a nucleoprotein-based influenza vaccine

Isabel Leroux-Roels (UGent) , Gwenn Waerlop (UGent) , Jessika Tourneur, Fien De Boever (UGent) , Catherine Maes (UGent) , Jacques Bruhwyler, Delphine Guyon-Gellin, Philippe Moris, Judith Del Campo, Paul Willems, et al.

(2022) FRONTIERS IN IMMUNOLOGY. 13.

Academic Bibliography

prof. Isabel Leroux-Roels

Immune responses in healthy adults elicited by a bivalent norovirus vaccine candidate composed of GI.4 and GII.4 VLPs without adjuvant

Safety and immunogenicity of a respiratory syncytial virus prefusion F (RSVPreF3) candidate vaccine in older adults : phase 1/2 randomized clinical trial

Human immunity and susceptibility to influenza A(H3) viruses of avian, equine, and swine origin

Respiratory syncytial virus prefusion F protein vaccine in older adults

Double-blind, placebo-controlled, dose-escalating study evaluating the safety and immunogenicity of an epitope-specific chemically defined nanoparticle RSV vaccine

Practice testing of generic quality indicators for responsible antibiotic use in nine hospitals in the Dutch–Belgian border area

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2) : results of a randomised, double-blind, placebo-controlled, phase 3 trial

A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccine

The role of cell-mediated immunity against influenza and its implications for vaccine evaluation

Randomized, double-blind, reference-controlled, phase 2a study evaluating the immunogenicity and safety of OVX836, a nucleoprotein-based influenza vaccine

Contents

Support

Contact